Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
656 grants for Others
Sorted by deadline (soonest first)
NIJ FY 2026 Research and Evaluation on Justice System Responses to Illegal Immigration
USDOJ-OJP-NIJ · O-NIJ-2026-172800
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
HHS-NIH11 · PAR-25-274
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-268
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-267
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
HHS-NIH11 · PAR-25-158
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
HHS-NIH11 · PAR-25-096
Tribal Broadband Connectivity Program
DOC-DOCNISTERA · 2026-NTIA-TBCP
Small Business Innovation Research and Small Business Technology Transfer Programs Phase II
USDA-NIFA · USDA-NIFA-SBIR-012221
Native Entities Grant Program
DOC-DOCNISTERA · 2026-NTIA-NEGP
National Science Foundation Translation to Practice (NSF TTP)
NSF · 25-540
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-371
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
HHS-NIH11 · PAR-25-369
DARRP Restoration Implementation Grants (2026)
DOC-DOCNOAAERA · NOAA-NMFS-HCPO-2026-33781
National Science Foundation Fostering Interdisciplinary Networks to Develop Emergent and Responsive Solutions Foundry (NSF FINDERS FOUNDRY)
NSF · 26-507
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
HHS-NIH11 · PAR-25-052
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
HHS-NIH11 · PAR-25-226
Improved quality of life of persons with disabilities in provinces heavily sprayed with agent orange in Ca Mau and Quang Ngai
DOS-VNM · OFOP0003897
Preschool Development Grant Birth Through Five (PDG B-5) SMART Grant
HHS-ACF · HHS-2026-ACF-ECD-TP-0039
Native American Affairs: Fiscal Year 2025 Colorado River Basin Tribal Drought Resiliency Program
DOI-BOR · R26AS00021
BJA FY 2026 Justice Reinvestment Initiative: Strengthening State and Local Operations to Reduce Crime and Recidivism
USDOJ-OJP-BJA · O-BJA-2026-172770
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
HHS-NIH11 · RFA-AT-25-003
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-RM-27-007
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-RM-27-016
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-RM-27-025
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
HHS-NIH11 · PA-23-317